PTA Balloon Catheters (Cardiovascular) - Global Market Analysis and Forecast Model
PTA Balloon Catheters (Cardiovascular) - Global Market Analysis and Forecast Model
Summary
PTA Balloon Catheters (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on PTA Balloon Catheters market for the year 2020 and beyond. Peripheral artery disease (PAD) is a global public health and socioeconomic problem affecting millions of patients each year and characterized by the build-up of atherosclerotic plaque in the lower extremity, carotid, and renal arteries, which disturbs normal blood flow.
Minimally Invasive technique is used to treat PAD with the help of Standard PTA Balloon Catheters that are used to open up the arteries that are blocked by plaque build-up (atherosclerosis). PTA Peripheral DEB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed PTA Balloon Catheters and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Intra-Peripheral PTA Balloon Catheters revenue by segment and market outlooks from 2015-2030.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Intra- PTA Balloon Catheters market.
- Competitive dynamics insights and trends provided for PTA Balloon Catheters.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Becton Dickinson and Co, Medtronic plc, Boston Scientific Corp, Abbott Laboratories, Koninklijke Philips N.V., Cardinal Health Inc, Cook Group Inc, QT Vascular Ltd, B. Braun Melsungen AG, Terumo Corp, Acotec Scientific Co Ltd, Kaneka Medix Corp, Lepu Medical Technology (Beijing) Co Ltd and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
ScopeThis Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the PTA Balloon Catheters marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to BuyThe model will enable you to -- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving PTA Balloon Catheters market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the PTA Balloon Catheters market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific PTA Balloon Catheters market from 2015-2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Please Note: this is delivered as an Excel.
Companies Mentioned
Becton Dickinson and Co
Medtronic plc
Boston Scientific Corp
Abbott Laboratories
Shockwave Medical Inc
Cardinal Health Inc
Koninklijke Philips N.V.
Cook Group Inc
QT Vascular
B. Braun Melsungen AG.
Terumo Corp
Acotec Scientific Co Ltd
Kaneka Corp
Lepu Medical Technology (Beijing) Co Ltd
Others